APA

Anandappa G., Lampis A., Cunningham D., Khan K. H., Kouvelakis K., Vlachogiannis G., Hedayat S., Tunariu N., Rao S., Watkins D., Starling N., Braconi C., Darvish-Damavandi M., Lote H., Thomas J., Peckitt C., Kalaitzaki R., Khan N., Fotiadis N., Rugge M., Begum R., Rana I., Bryant A., Hahne J. C., Chau I., Fassan M. & Valeri N. (20200805). miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Anandappa Gayathri, Lampis Andrea, Cunningham David, Khan Khurum H, Kouvelakis Kyriakos, Vlachogiannis Georgios, Hedayat Somaieh, Tunariu Nina, Rao Sheela, Watkins David, Starling Naureen, Braconi Chiara, Darvish-Damavandi Mahnaz, Lote Hazel, Thomas Janet, Peckitt Clare, Kalaitzaki Ria, Khan Nasir, Fotiadis Nicos, Rugge Massimo, Begum Ruwaida, Rana Isma, Bryant Annette, Hahne Jens C, Chau Ian, Fassan Matteo and Valeri Nicola. 20200805. miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Anandappa G., Lampis A., Cunningham D., Khan K. H., Kouvelakis K., Vlachogiannis G., Hedayat S., Tunariu N., Rao S., Watkins D., Starling N., Braconi C., Darvish-Damavandi M., Lote H., Thomas J., Peckitt C., Kalaitzaki R., Khan N., Fotiadis N., Rugge M., Begum R., Rana I., Bryant A., Hahne J. C., Chau I., Fassan M. and Valeri N. (20200805). miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Anandappa Gayathri, Lampis Andrea, Cunningham David, Khan Khurum H, Kouvelakis Kyriakos, Vlachogiannis Georgios, Hedayat Somaieh, Tunariu Nina, Rao Sheela, Watkins David, Starling Naureen, Braconi Chiara, Darvish-Damavandi Mahnaz, Lote Hazel, Thomas Janet, Peckitt Clare, Kalaitzaki Ria, Khan Nasir, Fotiadis Nicos, Rugge Massimo, Begum Ruwaida, Rana Isma, Bryant Annette, Hahne Jens C, Chau Ian, Fassan Matteo and Valeri Nicola. miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20200805.